The latest in animal models of pulmonary hypertension and right ventricular failure

O Boucherat, V Agrawal, A Lawrie, S Bonnet - Circulation research, 2022 - Am Heart Assoc
Pulmonary hypertension (PH) describes heterogeneous population of patients with a mean
pulmonary arterial pressure> 20 mm Hg. Rarely, PH presents as a primary disorder but is …

Metformin, macrophage dysfunction and atherosclerosis

X Feng, W Chen, X Ni, PJ Little, S Xu, L Tang… - Frontiers in …, 2021 - frontiersin.org
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to
treat many diseases. More and more evidence shows that metformin can regulate the …

Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week

M Guazzi, S Ghio, Y Adir - Journal of the American College of Cardiology, 2020 - jacc.org
Pulmonary hypertension (PH) associated with left heart disease, or Group 2 PH, includes
heart failure, valvular heart diseases, and congenital heart diseases. Although it is axiomatic …

Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening

SF Liu, N Nambiar Veetil, Q Li… - Frontiers in …, 2022 - frontiersin.org
Pulmonary hypertension (PH) is a progressive disease that arises from multiple etiologies
and ultimately leads to right heart failure as the predominant cause of morbidity and …

Myeloid cell derived IL1β contributes to pulmonary hypertension in HFpEF

V Agrawal, JA Kropski, JJ Gokey, E Kobeck… - Circulation …, 2023 - Am Heart Assoc
BACKGROUND: Pulmonary hypertension (PH) in heart failure with preserved ejection
fraction (HFpEF) is a common and highly morbid syndrome, but mechanisms driving PH …

Animal models of pulmonary hypertension: Getting to the heart of the problem

JP Dignam, TE Scott, BK Kemp‐Harper… - British Journal of …, 2022 - Wiley Online Library
Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease
due to the development of right ventricular (RV) failure. At present, no treatments targeted at …

Role of macrophages in pulmonary arterial hypertension

MQ Zhang, CC Wang, XB Pang, JZ Shi, HR Li… - Frontiers in …, 2023 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary vascular disease
characterized by progressive pulmonary artery pressure elevation, increased pulmonary …

A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the …

P Ameri, V Mercurio, P Pollesello… - European journal of …, 2024 - Wiley Online Library
Pulmonary hypertension (PH) associated with left heart failure (LHF)(PH‐LHF) is one of the
most common causes of PH. It directly contributes to symptoms and reduced functional …

Understanding the pathobiology of pulmonary hypertension due to left heart disease

JH Huston, SJ Shah - Circulation research, 2022 - Am Heart Assoc
The development of pulmonary hypertension (PH) is common and has adverse prognostic
implications in patients with heart failure due to left heart disease (LHD), and thus far, there …

Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life

J Selle, K Dinger, V Jentgen, D Zanetti, J Will… - Nature …, 2022 - nature.com
Obesity is a pre-disposing condition for chronic obstructive pulmonary disease, asthma, and
pulmonary arterial hypertension. Accumulating evidence suggests that metabolic influences …